GleamWall
中文EN

COR Cencora, Inc.

Wholesale-Drugs, Proprietaries & Druggists' Sundries · NYSE · SEC CIK 1140859 · Fiscal year ends 09/30

Financial factors as of 2026-06-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY5.1%
TTM net income YoY38.3%
TTM EPS YoY38.3%
Revenue 3-yr CAGR9.4%
Net income 3-yr CAGR15.8%

Margins

Gross margin4.0%
Operating margin0.9%
Net margin0.8%
FCF margin1.2%
EBITDA margin1.2%

Returns

ROE104.3%
ROA3.3%
ROIC (approx.)22.3%
Asset turnover4.22x

Leverage & solvency

Liabilities / assets96.1%
Debt / equity3.84x
Current ratio0.93x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.84x
Accruals ratio-2.8%
Payout ratio17.8%
Capex / revenue0.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-06-302026Q22026-03-312026Q12025-12-312025Q4*2025-09-302025Q32025-06-302025Q22025-03-312025Q12024-12-312024Q4*2024-09-30
Income statement
Revenue$84.75B$78.36B$85.93B$83.73B$80.66B$75.45B$81.49B$79.05B
Cost of revenue$81.15B$74.77B$82.86B$80.77B$77.76B$72.39B$78.93B$76.56B
Gross profit$3.61B$3.59B$3.07B$2.95B$2.91B$3.06B$2.56B$2.49B
SG&A expense$2.13B$1.98B$1.80B$1.75B$1.67B$1.60B$1.47B$1.49B
Operating income$1.12B$1.14B$760.45M$18.50M$867.65M$1.04B$706.25M$126.64M
Pretax income$996.39M$2.09B$708.64M-$187.04M$896.28M$928.66M$620.45M$125.18M
Income tax$219.73M$459.04M$142.51M$146.03M$206.53M$211.24M$126.73M$117.71M
Net income$763.52M$1.64B$559.65M-$339.70M$687.40M$717.87M$488.60M$3.38M
EBITDA$1.39B$1.39B$1.02B$277.27M$1.12B$1.30B$984.75M$881.66M
EPS (basic)3.958.442.88—3.553.702.52—
EPS (diluted)3.948.402.87—3.523.682.50—
Dividends declared per share0.600.600.600.550.550.550.550.51
Weighted avg. shares (diluted)193.94M195.38M195.32M—195.23M195.09M195.19M—
Balance sheet
Cash & equivalents$2.82B$2.18B$1.75B$4.36B$2.23B$1.98B$3.22B$3.13B
Receivables$25.45B$24.89B$25.98B$25.23B$24.56B$23.72B$24.55B$23.87B
Inventory$21.03B$20.01B$24.08B$20.49B$20.14B$18.97B$20.51B$19.00B
Current assets$55.34B$53.14B$54.15B$52.24B$48.81B$46.53B$49.99B$47.72B
PP&E, net$2.84B$2.81B$2.45B$2.54B$2.43B$2.30B$2.10B$2.18B
Goodwill$16.52B$16.45B$13.73B$13.68B$14.33B$14.09B$9.18B$9.32B
Intangibles$5.93B$6.05B$3.68B$3.77B$3.93B$3.86B$3.68B$4.00B
Total assets$83.81B$81.65B$78.36B$76.59B$73.96B$71.19B$69.05B$67.10B
Current liabilities$59.20B$56.13B$59.13B$57.82B$53.96B$53.33B$54.51B$54.28B
Short-term debt$279.15M$202.66M$342.28M$117.78M$196.79M$770.32M$2.21B$576.33M
Long-term debt$11.44B$12.18B$7.58B$7.54B$8.04B$7.09B$5.94B$3.81B
Total debt$11.72B$12.39B$7.92B$7.66B$8.24B$7.86B$8.15B$4.39B
Total liabilities$80.57B$78.07B$76.27B$74.84B$71.75B$70.01B$68.69B$66.31B
Shareholders' equity$3.05B$3.40B$1.91B$1.51B$1.98B$1.01B$226.58M$645.94M
Net debt$8.91B$10.21B$6.17B$3.30B$6.01B$5.88B$4.92B$1.26B
Shares outstanding190.83M194.56M194.52M193.94M193.86M193.78M193.85M194.94M
Cash flow statement
Operating cash flow$2.65B$1.34B-$2.31B$3.13B$109.25M$3.35B-$2.72B$1.00B
Capital expenditure$226.04M$165.62M$119.38M$249.81M$183.22M$129.06M$105.89M$182.32M
Free cash flow$2.43B$1.17B-$2.42B$2.88B-$73.97M$3.22B-$2.82B$818.05M
Investing cash flow-$240.15M-$4.87B-$299.31M-$321.94M-$234.69M-$4.08B-$343.04M-$241.88M
Financing cash flow-$1.77B$3.98B$43.20M-$683.78M$215.48M-$491.74M$3.21B-$957.26M
Depreciation & amortization$269.50M$249.29M$260.40M$258.77M$254.00M$259.82M$278.49M$755.02M
Stock-based compensation$28.73M$28.00M$66.05M$25.94M$23.18M$28.45M$70.38M$34.59M
Dividends paid$116.59M$117.46M$126.52M$107.51M$107.49M$111.19M$110.89M$100.94M
Share buybacks———$71,000$0$50.00M$385.40M$504.98M

Free plan shows the latest 8 periods; Pro shows all 73 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.